SecBot SecBot
8-K ·Filed Oct 26, 2026

ONCO

Onconetix, Inc.
NEUTRAL
Impact 3/10
Processed1h 8m ago SEC0001213900-26-112527
8-K context-dependent: Items 8.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-112527
Document: ea030972301ex99-1.htm0001213900-26-112527
Document: 0001213900-26-112527-index-headers.html0001213900-26-112527
Document: 0001213900-26-112527-index.html0001213900-26-112527
Document: 0001213900-26-112527.txt0001213900-26-112527
27 reports for ONCO
Performance horizon
67% Hit rate @ T+20 8 of 12 directional calls Went positive at some point 12 of 14 best @ T+60▲ +78.04%May 8, 2026
Filters
Rows
Reports for ONCO — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 3/10
$0.3500awaiting T+20—$0.3991 (+14.03%)
Oct 23, 2026
3d ago
DEFA14A
NEUTRAL ★ 2/10
$0.4180awaiting T+20—$0.3991 (−4.52%)
Oct 23, 2026
3d ago
8-K
NEUTRAL ★ 3/10
$0.4180awaiting T+20—$0.3991 (−4.52%)
Oct 23, 2026
3d ago
425
BEARISH ★ 6/10
$0.4180awaiting T+20—$0.3991 (+4.52%)
Oct 7, 2026
19d ago
DEF 14A
BEARISH ★ 7/10
$0.5970awaiting T+20—$0.3991 (+33.15%)
Sep 14, 2026
6w ago
DEFA14A / 8-K
NEUTRAL ★ 4/10
$0.6374 $0.5904▼ −7.37%▼ −9.64%$0.3991 (−37.39%)
Sep 14, 2026
6w ago
8-K
BEARISH ★ 6/10
$0.6374 $0.5904▲ +7.37%▲ +9.64%$0.3991 (+37.39%)
Sep 14, 2026
6w ago
425
BEARISH ★ 6/10
$0.6374 $0.5904▲ +7.37%▲ +9.64%$0.3991 (+37.39%)
Sep 4, 2026
7w ago
EFFECT
BEARISH ★ 8/10
$1.02 $0.6730▲ +34.02%▲ +34.62%$0.3991 (+60.87%)
Sep 3, 2026
7w ago
425
NEUTRAL ★ 3/10
$0.7390 $0.7337▼ −0.72%▲ +0.47%$0.3991 (−45.99%)
Showing 10 of 27

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh ONCO Intelligence

Analysis is for subscribers only.

Subscribe for Full Access